Can serum IL-6 be a sentinel biomarker of cancer cachexia in gynecologic cancer patients?
Autor: | Yoshihiro Kikuchi, Masashi Takano, Miyuki Horikoshi, Kenichi Furuya, Tsunekazu Kita, Kazuya Kudoh, Hiroko Kouta, Takayoshi Asakawa, Tomoyuki Yoshikwa |
---|---|
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Oncology Cancer Research medicine.medical_specialty 030109 nutrition & dietetics biology business.industry digestive oral and skin physiology Cancer cachexia Cancer musculoskeletal system medicine.disease 03 medical and health sciences Internal medicine Gynecologic cancer biology.protein Medicine Biomarker (medicine) business Interleukin 6 hormones hormone substitutes and hormone antagonists Cause of death |
Zdroj: | Journal of Clinical Oncology. 36:e17544-e17544 |
ISSN: | 1527-7755 0732-183X |
DOI: | 10.1200/jco.2018.36.15_suppl.e17544 |
Popis: | e17544Background: Cancer cachexia occurs in approximately 80% of cancer patients, and is the primary cause of death for 22–30% of all cancer patients. Cancer cachexia also diminishes quality of lif... |
Databáze: | OpenAIRE |
Externí odkaz: |